MOUNTAIN VIEW, Calif., July 31, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that a global biotechnology company has purchased WinNonlin AutoPilot(tm) to use in conjunction with its licenses of WinNonlin and Pharsight Knowledgebase Server(tm) (PKS(tm)). The customer is the seventh company to adopt WinNonlin AutoPilot.
